All regulatory updates
718 results found
European Commission posts updated RoHS exemptions tracker (“Exemptions list – validity and rolling plan”, Dec 2025)
The European Commission published an updated RoHS exemptions tracking file (“Exemptions list – validity and rolling plan”, Dec 2025) on its official document portal. While not a legal amendment to RoHS, the tracker is operationally important for compliance teams because it consolidates exemption validity/expiry status and supports forward planning for exemption renewals, product redesigns, and evidence management tied to Annex III/IV exemptions.
OEHHA issues request for relevant information on carcinogenicity of ethoprop (potential delisting review)
OEHHA posted a Request for Relevant Information on the carcinogenicity of ethoprop, indicating the chemical is being referred to the Carcinogen Identification Committee (CIC) for review for possible delisting from the Proposition 65 list. This is not a final delisting, but it is an official step in the delisting evaluation process and invites stakeholders to submit relevant data within OEHHA’s stated information-request window. Compliance teams tracking Proposition 65-listed substances should monitor this proceeding because it could eventually change listing status and related warning/enforcement exposure for ethoprop.
OEHHA request for relevant information on carcinogenicity of ethoprop (potential delisting review)
OEHHA issued a request for relevant information regarding the carcinogenicity of ethoprop as part of the Proposition 65 Carcinogen Identification Committee (CIC) process, indicating a potential delisting review pathway. Compliance teams that manufacture, distribute, or sell products that may involve ethoprop should monitor this review because a future delisting decision could change warning obligations, but no delisting has occurred at this stage.
European Commission publishes updated RoHS exemptions “validity and rolling plan” (Dec 2025)
The European Commission published an updated “Exemptions list – validity and rolling plan” document page (with an associated XLSX download) for RoHS Annex III/IV exemptions. While not itself a legal amendment, this Commission-hosted tracker is an authoritative compliance management resource for monitoring exemption validity periods, expirations, and the rolling plan of exemptions under review—supporting 2026 redesign/substitution planning, documentation updates, and exemption renewal tracking.
OEHHA request for relevant information on carcinogenicity of ethoprop (potential delisting review)
OEHHA issued a request for relevant information regarding the carcinogenicity of ethoprop in connection with a Carcinogen Identification Committee (CIC) review that could result in a potential delisting under Proposition 65. Compliance teams should monitor this proceeding because a delisting could change warning/settlement exposure for products/operations involving ethoprop; however, no delisting decision is indicated in the provided sources.
ECHA reports RAC/SEAC progressed EU-wide PFAS restriction evaluation; RAC opinion expected March 2026 and SEAC draft opinion to proceed to consultation
ECHA reported progress by its Committee for Risk Assessment (RAC) and Committee for Socio-Economic Analysis (SEAC) in evaluating the proposed EU-wide PFAS restriction under REACH. ECHA indicated RAC is expected to adopt its opinion in March 2026 and SEAC is expected to agree a draft opinion to be followed by a stakeholder consultation. Compliance teams should treat this as a timeline signal for when the restriction proposal could move closer to a Commission decision and begin preparing supply-chain use information and substitution planning for potentially affected PFAS uses.
ECHA December 2025 RAC/SEAC progress update: RAC opinion expected March 2026; SEAC draft opinion to proceed to consultation
ECHA’s meeting highlights report that RAC and SEAC continued evaluating the proposed EU-wide PFAS REACH restriction. ECHA indicated RAC was expected to adopt its opinion in March 2026, and SEAC was expected to agree a draft opinion intended for stakeholder consultation. Compliance teams should treat this as an important signal on the restriction’s procedural timeline and prepare for upcoming consultation inputs and potential downstream restriction scenarios.
ECHA December 2025 RAC/SEAC meeting highlights: PFAS restriction evaluation progressing; RAC opinion expected March 2026; SEAC draft opinion to follow
ECHA reported progress by the REACH committees (RAC and SEAC) on the proposed EU-wide PFAS restriction, indicating that RAC was expected to adopt its opinion in March 2026 and that SEAC would move toward agreeing a draft opinion for subsequent consultation. For compliance teams, this is a procedural milestone indicating when the proposal may advance to the next stage (consultation and eventual Commission decision), supporting planning for potential future PFAS restrictions across multiple sectors.
Rolling Action Plan: AICIS extends evaluation EVA00176 completion timeframe to 30 June 2026
AICIS issued a notice updating its Rolling Action Plan by extending the end date for chemical evaluation EVA00176 to 30 June 2026, citing the need to consult with relevant government agencies on matters arising during the evaluation. Companies with interest in the evaluated substance(s) should adjust internal tracking for evaluation outcomes and any downstream risk-management expectations tied to the evaluation timeline.
UN Depositary Notification communicates amendments to Annex A listing chlorpyrifos, MCCPs, and LC‑PFCAs
A UN Depositary Notification (C.N.672.2025.TREATIES-XXVII.15) communicates the COP-12-adopted amendments to Annex A of the Stockholm Convention to list chlorpyrifos, MCCPs, and LC‑PFCAs (their salts and related compounds). For compliance teams, this notification is a key procedural milestone for the amendments’ treaty lifecycle (including objection/non-acceptance procedures and entry-into-force mechanics) and should be monitored because national/regional implementing measures may reference the notification date and resulting timelines.
AICIS updates Rolling Action Plan (RAP) to extend EVA00176 evaluation completion date to 30 June 2026
AICIS updated its Rolling Action Plan timeline by extending the completion timeframe for evaluation EVA00176 to 30 June 2026, citing the need for consultation with relevant government agencies on matters arising during the evaluation. Compliance teams tracking RAP evaluations for potential downstream risk-management recommendations should update internal timelines and stakeholder monitoring plans accordingly.
ECHA Member State Committee agrees to identify n-hexane as an SVHC (precursor to Candidate List inclusion)
ECHA reported that its Member State Committee agreed to identify n-hexane as a Substance of Very High Concern (SVHC). This committee agreement is a formal REACH SVHC process milestone that precedes Candidate List inclusion and signals that downstream obligations (e.g., article communication/notification once listed) are expected to follow when ECHA updates the Candidate List accordingly.
ECHA Member State Committee meeting highlights: n-hexane agreed as SVHC (precursor to Candidate List inclusion)
ECHA published highlights from its Member State Committee (MSC) December meeting noting agreement to identify n-hexane as a substance of very high concern (SVHC). This is a formal step in the SVHC identification process under REACH and signals likely downstream Candidate List inclusion, which is relevant for companies to anticipate future Article 33 communication and related supply-chain compliance impacts once formally listed.
European Parliament press release: Parliament adopts targeted changes to postpone and simplify EUDR measures (application dates and simplified declaration concepts)
The European Parliament issued a press release stating that Parliament adopted targeted changes to the EUDR to postpone and simplify measures, including postponing application dates (large operators/traders to 30 Dec 2026; small operators to 30 Jun 2027) and referencing simplifications such as a one-off simplified declaration for micro & small primary operators and clearer allocation of due diligence statement responsibility to the first placer on the EU market. This item is an official institutional communication summarizing the adopted changes; for binding legal text, compliance teams should rely on the Official Journal publication of the amending regulation.
Commission publishes ‘environmental omnibus’ proposal (COM(2025) 981) to amend Battery Regulation (producer definition, labelling/substances of concern scope, and LMT battery removability/replaceability)
The European Commission issued COM(2025) 981, a proposal to amend Regulation (EU) 2023/1542. The research summary indicates the proposal would clarify the definition of “producer” (including non-established sellers regardless of sales technique), adjust the approach for removability/replaceability for LMT battery packs (module vs. cell-level), and clarify/simplify aspects of hazardous substance / substances-of-concern labelling (including reference to SVHCs). If adopted, these changes could affect producer responsibility determinations, product design/serviceability expectations for certain battery types, and compliance documentation/label content requirements.
European Commission publishes proposal COM(2025) 981 to amend Battery Regulation (producer definition, hazardous substance labelling scope, LMT removability/replaceability, reporting simplification)
The European Commission published a legislative proposal (COM(2025) 981) to amend Regulation (EU) 2023/1542. The proposal would (among other changes) clarify the producer definition to cover sellers established outside a Member State irrespective of selling technique, add precision to hazardous-substance labelling scope by referencing SVHC concepts under REACH/CLP, adjust removability/replaceability expectations for LMT battery packs to module level (rather than cell level) for safety/repairability balance, and streamline certain Commission reporting obligations related to Member State waste-battery data quality. This is not yet adopted; compliance teams should track the legislative process because the amendments could change producer/EPR scoping, labelling interpretation, and design-for-removal obligations for LMT batteries.
European Commission publishes proposal COM(2025) 982 to suspend authorised representative requirement for batteries EPR (Article 56(3)) until January 2035
The European Commission published a legislative proposal (COM(2025) 982) to suspend the application of Article 56(3) of Regulation (EU) 2023/1542 (authorised representative requirement linked to extended producer responsibility for batteries) until January 2035. If adopted, the change would reduce administrative burden for certain cross-border sales scenarios by altering when/where an authorised representative must be appointed for EPR purposes. This is a proposal (not yet adopted), and should be tracked for potential downstream impacts on EPR registration strategy and representation arrangements across Member States.
OEHHA adds N‑methyl‑N‑formylhydrazine to Proposition 65 list as a carcinogen (effective Dec 8, 2025)
OEHHA added N‑methyl‑N‑formylhydrazine to the Proposition 65 list as a chemical known to cause cancer. Businesses selling products in California should evaluate whether the chemical is present in products or workplace/consumer exposure scenarios and determine if Prop 65 warning, reformulation, or exposure mitigation actions are needed based on anticipated exposure pathways.
OEHHA adds N-methyl-N-formylhydrazine to the Proposition 65 list as a chemical known to cause cancer
OEHHA added N-methyl-N-formylhydrazine to the Proposition 65 list as a chemical known to cause cancer (effective December 8, 2025). Compliance teams should evaluate whether products, emissions, or workplace activities could expose individuals in California to this substance and whether Prop 65 warnings or exposure assessments are required.
OEHHA adds developmental toxicity endpoint to Bisphenol S (BPS) Proposition 65 listing (effective Dec 8, 2025)
OEHHA issued a listing notice expanding the existing Proposition 65 reproductive toxicity listing for Bisphenol S (BPS) by adding the developmental toxicity endpoint. This change means Prop 65 warnings/enforcement considerations for BPS exposures now explicitly include developmental toxicity, in addition to previously covered reproductive toxicity endpoints, affecting product hazard assessments and warning determinations for businesses selling into California.